Fish Oil Vit D Gleam | Allergy Update

From eNewsletter 2/28/2024

DID YOU KNOW that an enormously important study from last month's Arthritis & Rheumatology received very little national media coverage? 

This was a follow-up to the study showing 5 years of vitamin D supplementation was associated with a 22% reduction in risk for confirmed autoimmune diseases, and 5 years of omega-3 fatty acid supplementation was associated with an 18% reduction in confirmed and probable incident autoimmune diseases.

The authors found that in those who discontinued vitamin D, the beneficial effects waned after the supplement was discontinued, while the protection from omega-3 fatty acid supplementation lived on for at least 2 additional years.

The national message from public health experts should be to continue both supplements in perpetuity!

To read the rest of this issue, please go to this page.

Switching Diets Warning | Double Sale

From eNewsletter 2/26/2024

DID YOU KNOW that a study from Frontiers in Nutrition found that higher serum ascorbic acid levels are associated with a reduced prevalence of depression?

For those who do not know, ascorbic acid is vitamin C.

Another study from BMC Public Health found that vitamin C is effective in reducing the severity and duration of the common cold. Subjects in good health using at least 1000 mg daily resulted in a 15-26% reduction in severity of symptoms.

To read the rest of today's issue, please go to this page.

Cancer Prevention Special

From eNewsletter 2/21/2024

DID YOU KNOW that cancer survivors who adhere to a healthy lifestyle, which includes never smoking, light or no alcohol intake, sufficient physical activity, a healthy diet, and an optimal body mass index, may lower their risk for cancer-related and all-cause mortality, according to new research from International Journal of Cancer? 

Adherence to a healthy lifestyle (4-5 healthy lifestyle factors) vs an unfavorable lifestyle (0-1 healthy lifestyle factor) was associated with a 43% reduction in the risk for cancer-related mortality and a 48% reduction in the risk for all-cause mortality.

For more on this cancer special issue, please go to this page.